Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00406393
What this trial is testing

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Medical College of Wisconsin 304
Large-scale testing (Phase 3)Looking for participantsNCT03818334
What this trial is testing

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Bone Marrow Transplant ComplicationsGraft Versus Host DiseaseInfection Viral+2 more
Hospital Israelita Albert Einstein 50
Testing effectiveness (Phase 2)Study completedNCT00144703
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Who this might be right for
Hematologic MalignanciesMyelogenous LeukemiaAcute Lymphoblastic Leukemia+3 more
Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)Study completedNCT07319000
What this trial is testing

Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Hospital Universitario Dr. Jose E. Gonzalez 35
Large-scale testing (Phase 3)Study completedNCT01788501
What this trial is testing

Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Seoul National University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT04859946
What this trial is testing

Itacitinib for the Prevention of Graft Versus Host Disease

Who this might be right for
Hematologic and Lymphocytic Disorder
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)WithdrawnNCT04961801
What this trial is testing

Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia

Who this might be right for
LymphomaLeukemia
Shin Mineishi
Testing effectiveness (Phase 2)Study completedNCT00520130
What this trial is testing

Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

Who this might be right for
Myelodysplastic SyndromeHodgkin's LymphomaNon-Hodgkin's Disease+2 more
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)UnknownNCT01941394
What this trial is testing

Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation

Who this might be right for
Graft-versus-host DiseaseRelapse
National Research Center for Hematology, Russia 70
Testing effectiveness (Phase 2)UnknownNCT06279494
What this trial is testing

Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesSevere Aplastic Anemia
Peking University People's Hospital 6
Testing effectiveness (Phase 2)Study completedNCT02208037
What this trial is testing

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplasia+6 more
National Heart, Lung, and Blood Institute (NHLBI) 279
Large-scale testing (Phase 3)Study completedNCT00928018
What this trial is testing

Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

Who this might be right for
Non-hodgkin LymphomaHodgkin Lymphoma
Dana-Farber Cancer Institute 139
Testing effectiveness (Phase 2)UnknownNCT03395860
What this trial is testing

Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT

Who this might be right for
Graft-versus-host-diseaseProphylaxis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT01509560
What this trial is testing

PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood

Who this might be right for
Condition After Allogenic Peripheral Stem Cell Transplantation (SCT)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Testing effectiveness (Phase 2)UnknownNCT02799888
What this trial is testing

Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation

Who this might be right for
Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
Affiliated Hospital to Academy of Military Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00800839
What this trial is testing

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Who this might be right for
Hematologic DiseasesLeukemiaLymphoma+1 more
M.D. Anderson Cancer Center 56
Large-scale testing (Phase 3)Looking for participantsNCT07689630
What this trial is testing

Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT

Who this might be right for
Graft Versus Host DiseaseHematologic Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186
Testing effectiveness (Phase 2)Study completedNCT00133367
What this trial is testing

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

Who this might be right for
Multiple MyelomaNon-Hodgkin's LymphomaHodgkin's Disease+2 more
Massachusetts General Hospital 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06480630
What this trial is testing

Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases

Who this might be right for
Acute Graft Versus Host DiseaseMalignant Hematologic Neoplasm
Anhui Provincial Hospital 39
Next Page